Fennec Pharmaceuticals Inc. (FENC): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$1.26M
Year ended 2023-12-31
2022-12-31: $86.0K2023-12-31: $1.26M$1.26M
2022-12-31 Cost of Revenue (USD) 2023-12-31
Period endedCost of RevenueChange YoYSource filing
2023-12-31$1.26Mn/m2024-03-29, From 2023-01-01
2022-12-31$86.0Kn/a2024-03-29, From 2022-01-01